nope, you argued that ropren would never be given approval by the RMOH and would demand an expensive phase 3 clinical trial. a manufacturing license is a completely different issue. dont worry tharlow, i dont think anyone here expected you to live up to you word. you have zero credibility. back on igniore for you.
- Forums
- ASX - By Stock
- SLA
- heading lower on profit taking
heading lower on profit taking, page-6
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)